Congressional Testimony 2008

-

September

09/25/2008 FDA's Role--Antimicrobial Resistance
Bernadette Dunham, D.V.M., Ph.D., before the House Committee on Agriculture, Subcommittee on Livestock, Dairy, and Poultry
09/17/2008 FDA Food Protection Plan/Action Plan for Import Safety
David Acheson, M.D., F.R.C.P., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
09/17/2008 FDA Oversight of Direct-to-Consumer Advertising of Medical Devices
Daniel Schultz, M.D., before the Senate Special Committee on Aging

-

07/31/2008 Ongoing Investigation of Salmonella Saintpaul Outbreak
David Acheson, M.D., F.R.C.P., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
07/30/2008 Investigation of Salmonella Saintpaul Outbreak
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture, Subcommittee on Horticulture and Organic Agriculture
07/09/2008 FDA's Role in Identifying and Communicating Drug Safety Issues
Paul Seligman, M.D., M.P.H., before the House Committee on Veterans' Affairs

-

06/24/2008 FDA's Role in Antimicrobial Resistance
Linda Tollefson, D.V.M., M.P.H., before the Senate Committee on Health, Education, Labor, and Pensions
06/12/2008 Ongoing Efforts to Enhance Food Safety
David Acheson, M.D., F.R.C.P., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
06/10/2008 Bisphenol-A (BPA)
Norris Alderson, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Commerce, Trade and Consumer Protection
06/05/2008 Reauthorization of ADUFA and the Proposed AGDUFA
Bernadette M. Dunham, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health

-

05/14/2008 The Safety of Medical Products Regulated by FDA
Randall Lutter, Ph.D., before the House Committee on Oversight and Government Reform
05/14/2008 BPA (Bisphenol-A)
Norris Alderson, Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Consumer Affairs, Insurance, and Automotive Safety
05/14/2008 Discussion Draft of the "Food and Drug Administration Globalization Act" Legislation: Device and Cosmetic Safety
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
05/01/2008 Discussion Draft of the "Food and Drug Administration Globalization Act" Legislation: Drug Safety
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health

-

04/29/2008 FDA’s Ongoing Heparin Investigation
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
04/25/2008 Chinese Seafood Imports
Don Kraemer, before the U.S. and China Economic and Security Review Commission
04/24/2008 Food and Cosmetic Provisions of the "Food and Drug Administration Globalization Act" Discussion Draft Legislation
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
04/22/2008 Safety of Medical Products with Foreign Components
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
04/15/2008 Fiscal Year 2009 Budget Request
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
04/02/2008 Biologics Program--Funding
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies

-

03/12/2008 Enhancing Food Safety
Stephen F. Sundlof, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

-

02/27/2008 Drug Safety--Funding
Janet Woodcock, M.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies

-

01/29/2008 Science at FDA
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

-